Mainz University Medical Centre, 40 patients. Immunoadsorption stripped GPCR autoantibodies from blood, but Long COVID symptoms did not improve versus sham, and adverse events were more common.
www.thelancet.com/journals/lan...
Immunoadsorption was not effective in reducing symptom burden in post-Covid syndrome.
